Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
Authors
Keywords
-
Journal
EUROPACE
Volume 17, Issue 2, Pages 187-193
Publisher
Oxford University Press (OUP)
Online
2014-09-19
DOI
10.1093/europace/euu225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel
- (2014) Raffaele de Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran and rivaroxaban prescription for atrial fibrillation in Catalonia, Spain: the need to manage the introduction of new drugs
- (2013) Amelia Troncoso et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and Safety of Dabigatran Etexilate and Warfarin in “Real-World” Patients With Atrial Fibrillation
- (2013) Torben Bjerregaard Larsen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants
- (2013) Charalampos Kasmeridis et al. PHARMACOECONOMICS
- Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
- (2013) Benjamin A. Steinberg et al. Journal of the American Heart Association
- National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011
- (2012) Kate Kirley et al.
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPACE
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
- (2012) Jonas Bjerring Olesen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
- (2011) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
- (2010) Morten L. Hansen et al. ARCHIVES OF INTERNAL MEDICINE
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPACE
- Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study
- (2010) Charlotte Andersson et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started